Axsome Therapeutics (AXSM) PT Lowered to $29 at BofA Securities After KOL Call
Tweet Send to a Friend
BofA Securities analyst Jason Gerberry lowered the price target on Axsome Therapeutics (NASDAQ: AXSM) to $29.00 (from $35.00) after speaking ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
